Tianjin TEDA Biomedical Engineering Company Limited

Informe acción SEHK:8189

Capitalización de mercado: HK$418.7m

Salud financiera de hoja de balance de Tianjin TEDA Biomedical Engineering

Salud financiera controles de criterios 4/6

Tianjin TEDA Biomedical Engineering tiene un patrimonio de los accionistas total de CN¥59.1M y una deuda total de CN¥98.7M, lo que sitúa su ratio deuda-patrimonio en 167.1%. Sus activos y pasivos totales son CN¥310.1M y CN¥251.0M respectivamente.

Información clave

167.1%

Ratio deuda-patrimonio

CN¥98.65m

Deuda

Ratio de cobertura de interesesn/a
EfectivoCN¥92.73m
PatrimonioCN¥59.05m
Total pasivoCN¥251.00m
Activos totalesCN¥310.05m

Actualizaciones recientes sobre salud financiera

Recent updates

There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 73% Price Jump

Oct 17
There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 73% Price Jump

There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 38% Price Jump

Aug 16
There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 38% Price Jump

Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) 26% Share Price Plunge Could Signal Some Risk

May 07
Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) 26% Share Price Plunge Could Signal Some Risk

Is Tianjin TEDA Biomedical Engineering (HKG:8189) Weighed On By Its Debt Load?

Sep 12
Is Tianjin TEDA Biomedical Engineering (HKG:8189) Weighed On By Its Debt Load?

Investors Give Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Shares A 28% Hiding

Apr 17
Investors Give Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Shares A 28% Hiding

Is Tianjin TEDA Biomedical Engineering (HKG:8189) A Risky Investment?

Apr 07
Is Tianjin TEDA Biomedical Engineering (HKG:8189) A Risky Investment?

Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Nov 01
Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Tianjin TEDA Biomedical Engineering (HKG:8189) Is Making Moderate Use Of Debt

Apr 21
Tianjin TEDA Biomedical Engineering (HKG:8189) Is Making Moderate Use Of Debt

Is Tianjin TEDA Biomedical Engineering (HKG:8189) Using Too Much Debt?

Oct 26
Is Tianjin TEDA Biomedical Engineering (HKG:8189) Using Too Much Debt?

Tianjin TEDA Biomedical Engineering (HKG:8189) Has Debt But No Earnings; Should You Worry?

Apr 06
Tianjin TEDA Biomedical Engineering (HKG:8189) Has Debt But No Earnings; Should You Worry?

Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Dec 22
Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CN¥200.4M) de 8189 no cubren sus pasivos a corto plazo (CN¥224.2M).

Pasivo a largo plazo: Los activos a corto plazo de 8189 (CN¥200.4M) superan a sus pasivos a largo plazo (CN¥26.8M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (10%) de 8189 se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de 8189 ha crecido de 16.6% a 167.1% en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: 8189 tiene suficiente cash runway para más de 3 años basándose en su flujo de caja libre actual.

Pronóstico de cash runway: 8189 dispone de suficiente cash runway para 1.6 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 10.5% cada año.


Descubre empresas con salud financiera